Didem Taştekin

6PUBLICATIONS
33CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 19, 2026
Prevalence and Reactivation of Hepatitis B and C in Patients Undergoing Chemotherapy for Solid Tumors.

Mustafa Gürbüz, Deniz Tural, Timuçin Çil

|Jan 28, 2026
Evaluating Comorbidity Scores in Geriatric Ovarian Cancer: A Retrospective Cohort Analysis.

Simay Cokgezer, Naziye Ak, Muhammet Senkal

|Oct 13, 2022
Quantification of cell-free circulating mitochondrial DNA copy number variation in hepatocellular carcinoma.

Burhanettin Yalçınkaya, Didem Tastekin, Fatih Güzelbulut

|Sep 09, 2022
Capecitabine and temozolomide (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors.

Izzet Dogan, Didem Tastekin, Senem Karabulut

|Jan 17, 2022
FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer.

Seval Ay, Muhammed Mustafa Atcı, Rukiye Arıkan

|Oct 24, 2020
Role of mir-33a, mir-203b, mir361-3p, and mir-424 in hepatocellular carcinoma

Burhanettin Yalçınkaya, Esra Güzel, Didem Taştekin

Pageof 1